EUVIMEDEUVIMED entdecken
Open Access

Identification and validation of a prognostic signature of m5C-related genes for esophageal cancer

Zhengrong Huang, Ying Peng, Siqian Cai, Liyan Wang, Hanwen Lin, Jiaying Qiu, Yaqi Wen, Yixin Chen, Yuanmei Chen, Yuanji Xu, Zhizhong Lin, Jingjing Dong und 1 weitere

Journal of Thoracic Disease · 2025-06 · 17 (6) · 4117-4135

DOI: 10.21037/jtd-2025-768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2025-06. Verfasst von Zhengrong Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Traditional Chinese and Western Medicine, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fu…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal cancer (ESCA) is one of the most common malignancies, and has a poor prognosis. The role of 5-methylcytosine (m5C) regulators has been linked to carcinogenesis in a number of cancers. However, the role of m5C regulators in ESCA is unclear. This study sought to examine the relationships between m5C regulators and the tumorigenesis of ESCA.

Methods

Based on the expression of the m5C regulators in 11 normal tissue and 142 tumor tissue samples from The Cancer Genome Atlas (TCGA) database, two ESCA subtypes were identified. The two ESCA subtypes, normal and tumor tissue samples from TCGA, and normal and tumor tissue samples from validation datasets were analyzed to identify the differentially expressed genes (DEGs). To investigate the biological function of the m5C regulators in ESCA, a functional analysis was conducted, and a prognostic model was established. Using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), PLA2G2F, HHIP, TNXB, and STK31 expression was detected in the ESCA and adjacent esophageal tissues.

Results

The m5C regulators, including TRDMT1, NSUN2, NSUN4, NSUN6, DNMT1, ALYREF, and YBX1, were upregulated in the ESCA subtype 2 group. Further, the gene set variation analysis (GSVA) and correlation analysis revealed that the m5C regulators were positively correlated with the E2 promoter-binding factor (E2F) transcription factor 1 targets and the G2 phase to M phase checkpoint (G2M), and were negatively correlated with tumor necrosis factor-signaling via nuclear factor kappa beta pathways. Four independent prognostic genes (i.e., PLA2G2F, HHIP, TNXB, and STK31) were selected to construct a model to predict the prognosis of ESCA patients. According to the RT-qPCR analysis, PLA2G2 expression was higher in the ESCA tissues than the adjacent tissues, while STK31, HHIP, and TNXB expression was lower.

Conclusions

Two subtypes of m5C regulators in ESCA patients were explored. Our findings may improve the understanding of m5C regulators in the biology of ESCA.

Schlagwörter

Stichwörter der Autor:innen

5-methylcytosine regulators (m5C regulators)Esophageal cancer (ESCA)nomogramprognostic model

Autor:innen und Institutionen

  • Department of Integrative Traditional Chinese and Western Medicine, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fujian Cancer Hospital, Fuzhou, China.
  • Department of General Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.

Zitieren

APA

Huang, Z., Peng, Y., Cai, S., Wang, L., Lin, H., Qiu, J., Wen, Y., Chen, Y., Chen, Y., Xu, Y., Lin, Z., Dong, J., & Peng, H. (2025). Identification and validation of a prognostic signature of m5C-related genes for esophageal cancer. Journal of Thoracic Disease, 17(6), 4117-4135. https://doi.org/10.21037/jtd-2025-768

Vancouver

Huang Z, Peng Y, Cai S, Wang L, Lin H, Qiu J, et al. Identification and validation of a prognostic signature of m5C-related genes for esophageal cancer. Journal of Thoracic Disease. 2025;17(6):4117-4135. doi:10.21037/jtd-2025-768

BibTeX
@article{Huang2025,
  author = {Huang, Zhengrong and Peng, Ying and Cai, Siqian and Wang, Liyan and Lin, Hanwen and Qiu, Jiaying and Wen, Yaqi and Chen, Yixin and Chen, Yuanmei and Xu, Yuanji and Lin, Zhizhong and Dong, Jingjing and Peng, Haiyan},
  title = {Identification and validation of a prognostic signature of m5C-related genes for esophageal cancer},
  journal = {Journal of Thoracic Disease},
  year = {2025},
  volume = {17},
  number = {6},
  pages = {4117--4135},
  doi = {10.21037/jtd-2025-768}
}
Kostenlos starten →